Ethical investments are primarily about taking stakes in companies that have a positive social impact. However, an investment’s financial profitability should also be carefully evaluated.
Fund managers are still accountable to their investors, and they have to ensure that profits will be made even from ethical equities. This is exactly the point of Australian Ethical Investment (AEF) in taking stakes in some New Zealand companies. It chooses businesses that promote positive impacts in areas like health and environment, but it also makes sure that it will make profits from the investments.
Investing in these companies have proven to be profitable for Australia’s leading ethical fund manager. According to Andy Gracey, the portfolio manager of AEF’s Australian Shares Fund, New Zealand’s equities have performed very well for the past 10 years. His fund has invested primarily in healthcare-related stocks, but it is also looking for technology-related ones, particularly in clean energy.
The Australian Shares Fund does not invest in companies that it deems bad for the society or the environment such as those in liquor, mining, and non-renewable energy sectors. However, the fund also formerly invested in fossil fuel as means of transitioning into renewable, but since 2012, it has completely divested its investments in such stocks.
Gracey said that the fund does not make any distinction between Australian and Kiwi businesses. Quality in terms of social responsibility and financial viability is always the basis for assessing investment opportunities. Approximately 10 percent of his firm’s AU$800 million fund is invested in New Zealand companies. AEF also manages the funds of some Kiwi corporations that have investments in Australian corporations.
Some of the Kiwi investments that brought the best returns to the Australian fund are in the areas of healthcare (Fisher & Paykel Healthcare), renewable energy (Mercury NZ, Meridian Energy, and Contact Energy), and sustainable technology (Vista Group and Gentrack Group).
Fisher & Paykel Healthcare is one of the long-term investments in the AEF New Zealand portfolio. The fund manager also considers it as its best-performing. It is a well-managed healthcare technology provider that focuses on respiratory ventilation support both for hospital and home use. With regards to market performance, its earnings are expected to increase by more than 62 percent in the coming years, Yahoo! Finance reported. It is currently being traded at NZ$12.94 per share. It has so far delivered about 20 percent dividends for the fund management company.
When it comes to potential growth and long-term viability, the fund manager is also betting on the renewable energy sector of New Zealand. Approximately 80 percent of its electric energy production is from renewable sources, primarily from hydropower and geothermal plants. Some emerging energy companies in the country are also focusing on other sources such as solar and wind power.
From a purely financial aspect, the long-term viability of investing in Kiwi firms seems solid. Australian socially responsible investors are likely to be attracted by the prospects of financial sustainability coupled with environmental sustainability.
Chainlink (LINK) with big update and new possibilities
Chainlink has released the OCR (Off-Chain Reporting) update, which can open up new data sources and generally increases performance. It...
Mazzanti manufacturer launches a STO after three equity crowdfunding campaigns
The campaign launched by Mazzanti has a duration of 60 days and has a minimum target of $964,000 (€800,000) and...
Gimme5 and Conto Lingotto enter Nexi Open, Nexi’s ecosystem for open banking
In 2020, Nexi Group reported Ebitda of $724.3 million (€601.4 million), up 2.5%, against revenues down 2.8% to around $1.25...
Why cotton futures made a new weekly chart high close
Cotton futures were higher for the week and made a new weekly chart high close once again. The weekly export...
Silver Supply Shortage: What Investors Need to Know
Precious metals received renewed interest as investment vehicles in the face of a global pandemic, as inflation-proof hedges in an...
Crypto6 days ago
Bitcoin slips back to $53,000 and major altcoins go lower on February 22nd
Biotech6 days ago
BB Biotech: Positive development in a volatile market environment
Featured6 days ago
The keys to ESG investment in 2021 in the face of growing interest and profitability
Business5 days ago
Virtual Reality (VR) mingles with team sports